
Investors Face Losses as GRAIL Securities Class Action Proceeds
Investors who purchased GRAIL, Inc. common stock between May 13, 2025, and February 19, 2026, are now eligible to join a class action lawsuit. The litigation, filed in the Northern District of California, accuses the healthcare company and its executives of misleading shareholders regarding the clinical trial results of their flagship cancer test.


























